Orexigen Therapeutic (OREX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OREX | ACXP | ASBP | ||
| Company | Orexigen Therapeutic | Acurx Pharmaceuticals Inc | Aspire Biopharma Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.25 | 1.9800 | 1.5800 | ||
| High | 0.32 | 2.0000 | 1.5800 | ||
| Low | 0.22 | 1.9100 | 1.4100 | ||
| Latest | 0.22 | 1.9100 | 1.5500 | ||
| Change | -0.12 | -0.0700 | -0.0400 | ||
| % Change | -34.41% | -3.54% | -2.52% | ||
| Volume | 3,735,400 | 19,100 | 168,000 | ||
| 20-Day Average Volume | 2,308,280 | 38,705 | 1,441,105 | ||
| Previous Close | 0.34 | 1.9800 | 1.5900 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.47 | 2.2935 | 1.5948 | ||
| 20-Day Raw Stochastic | 4.24% | 2.00% | 28.00% | ||
| 20-Day Relative Strength | 32.36 | 31.55 | 37.86 | ||
| Weighted Alpha | -72.99 | -91.97 | -90.38 | ||
| Today's Opinion | N/A | 100% Sell | 100% Sell | ||
| Previous Opinion | N/A | 100% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.37% since 03/27/18 | -7.28% since 02/10/26 | +9.93% since 02/10/26 | ||
| Low | 0.17 on 03/28/18 | 1.8900 on 02/13/26 | 1.2000 on 02/12/26 | ||
| High | 0.39 on 04/02/18 | 2.0900 on 02/11/26 | 1.6300 on 02/17/26 | ||
| 1-Month | |||||
| %Chg | -81.57% since 03/02/18 | -27.92% since 01/16/26 | -29.86% since 01/16/26 | ||
| Low | 0.17 on 03/27/18 | 1.8900 on 02/13/26 | 1.2000 on 02/12/26 | ||
| High | 1.42 on 03/09/18 | 2.8900 on 01/23/26 | 2.4500 on 01/30/26 | ||
| 3-Month | |||||
| %Chg | -82.02% since 01/03/18 | -55.99% since 11/18/25 | -63.34% since 11/18/25 | ||
| Low | 0.17 on 03/27/18 | 1.8900 on 02/13/26 | 1.2000 on 02/12/26 | ||
| High | 1.60 on 02/22/18 | 4.6004 on 12/08/25 | 6.8400 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | -89.17% since 10/03/17 | -62.91% since 08/18/25 | -93.43% since 08/18/25 | ||
| Low | 0.17 on 03/27/18 | 1.8900 on 02/13/26 | 1.2000 on 02/12/26 | ||
| High | 2.32 on 10/13/17 | 8.3400 on 10/08/25 | 26.0000 on 08/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,212 | 4,864 | 4,165 | ||
| Shares Outstanding, K | 18,890 | 2,547 | 2,687 | ||
| Annual Sales | 33,710,000 | 0 | 0 | ||
| Annual Net Income | -24,520,000 | -14,100,000 | -12,540,000 | ||
| Last Quarter Sales | 18,900,000 | 0 | 0 | ||
| Last Quarter Net Income | -20,830,000 | -1,990,000 | -1,850,000 | ||
| 60-Month Beta | 2.46 | -1.22 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.35 on 11/13/17 | -1.23 on 11/12/25 | -0.04 on 11/14/25 | ||
| Latest Earnings Date | 05/08/18 | 03/13/26 | 04/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||